Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.54 |
| ▸ | BRD4 | O60885 | 1/20 | 0.51 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.49 |
| ▸ | PRKCB | P05771 | 2/20 | 0.47 |
| ▸ | PRKCA | P17252 | 2/20 | 0.47 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.47 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.47 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lycogalic Acid A SCHEMBL12955978 | 1.00 | ALDH1A1 (0.54) | ALDH1A1KDM4EMAPTHPGDLMNA | |
| SCHEMBL5432407 | 0.90 | ALDH1A1 (0.64) | ALDH1A1KDM4EMAPTHPGDLMNA | |
| Lycogarubin C SCHEMBL12658123 | 0.81 | NR4A2 (0.59) | ALDH1A1KDM4EMAPTLMNACYP1A2 | |
| Lycogarubin C SCHEMBL30742812 | 0.81 | NR4A2 (0.59) | ALDH1A1KDM4EMAPTLMNACYP1A2 | |
| SCHEMBL23057359 | 0.78 | BRD4 (0.50) | ALDH1A1KDM4EMAPTHPGDLMNA | |
| SCHEMBL12658020 | 0.78 | F7 (0.60) | GPR84 | |
| SCHEMBL22443303 | 0.75 | PDE10A (0.55) | ALDH1A1KDM4EMAPTLMNACYP1A2 | |
| SCHEMBL3333256 | 0.75 | MEN1 (0.50) | ALDH1A1KDM4EMAPTHPGDGPR84 | |
| SCHEMBL21067626 | 0.75 | NR4A2 (0.47) | ALDH1A1KDM4EHPGDPBRM1 | |
| SCHEMBL9272191 | 0.75 | MAPT (0.53) | ALDH1A1KDM4EMAPTHPGDLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260092179-A1 | GENETICALLY MODIFIED HOST CELLS PRODUCING VIOLACEIN, ANALOGUES, AND DERIVATIVES THEREOF | OCTARINE BIO APS (DK) | 2026-04-02 | — | — | US | disclosed |
| CN-118109531-A | Method for synthesizing indole-3-pyruvic acid in vitro by using enzyme catalysis | 安阳尼采启合生物科技有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-117402099-A | Synthesis method of polysubstituted pyrrole compound | 常州大学 | 2024-01-16 | — | — | CN | disclosed |
| US-20230094365-A1 | PIM KINASE INHIBITOR COMPOSITIONS, METHODS, AND USES THEREOF | SNAP BIO, INC. | 2023-03-30 | — | — | US | disclosed |
| US-20220274997-A1 | PIM KINASE INHIBITOR COMPOSITIONS AND USES THEREOF | SNAP BIO, INC. | 2022-09-01 | — | — | US | disclosed |
| US-11319320-B2 | PIM kinase inhibitor compositions, methods, and uses thereof | SNAP BIO, INC. (US) | 2022-05-03 | — | — | US | disclosed |
| EP-3962916-A1 | PIM KINASE INHIBITOR COMPOSITIONS AND USES THEREOF | Snap Bio, Inc. (US) | 2022-03-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230094365-A1 | PIM KINASE INHIBITOR COMPOSITIONS, METHODS, AND USES THEREOF | PIM1, PIM3, PIM2 | ALDH1A1 2777/4885KDM4E 756/4885MAPT 3219/4885 |
| US-20260092179-A1 | GENETICALLY MODIFIED HOST CELLS PRODUCING VIOLACEIN, ANALOGUES, AND DERIVATIVES THEREOF | TDO2, BLVRB, INMT | ALDH1A1 1612/4885KDM4E 1143/4885MAPT 1741/4885 |
| US-20220274997-A1 | PIM KINASE INHIBITOR COMPOSITIONS AND USES THEREOF | PIM1, PIM2, PIM3 | ALDH1A1 3022/4885KDM4E 929/4885MAPT 3723/4885 |
| US-11319320-B2 | PIM kinase inhibitor compositions, methods, and uses thereof | PIM1, PIM2, PIM3 | ALDH1A1 2228/4885KDM4E 730/4885MAPT 3881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.